Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $140,364 - $217,352
-5,380 Closed
0 $0
Q1 2021

Jun 02, 2022

BUY
$33.06 - $56.93 $177,862 - $306,283
5,380 New
5,380 $206,000
Q1 2021

May 11, 2021

SELL
$33.06 - $56.93 $177,862 - $306,283
-5,380 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$28.43 - $44.67 $152,953 - $240,324
5,380 New
5,380 $233,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.